Piramal Pharma Limited Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹167.69Market Cap
₹ 22,325 Cr.Stock P/E
ROE
-3.58 %RSI
65.2Trend
BearishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments (1) Contract development and manufacturing organisations (CDMO), (2) Complex hospital generics (critical care), and (3) consumer healthcare (OTC). Company entered Pharma space back in 1988 with acquisition of Nicholas Laboratories and grew through a series of Mergers & Acquisitions[1] and various organic initiatives. In 2010 the Domestic formulations business was sold to Abott for $3.7 billion[2] and Diagnostic Services was sold to Super Religare Laboratories (SRL)[3]
Piramal Pharma Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Piramal Pharma Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Piramal Pharma Ltd share price chart currently indicates a Bearish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 167.69 |
| RSI (14) | 65.2 |
| 50 DMA | 167.73 |
| 200 DMA | 172.66 |
| Trend | Bearish |
| A/D Rating | A+ |
| RS Rating | 43 |
| EPS Rating | 3 |
| TI65 | 1.02 |
| TI65 Trend | Neutral |
Pivot Points Analysis
Daily pivot points for Piramal Pharma Limited calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹179.13 |
| R2 | ₹176.22 |
| R1 | ₹171.95 |
| PP | ₹169.04 |
| S1 | ₹164.77 |
| S2 | ₹161.86 |
| S3 | ₹157.59 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 22,325 Cr. |
| Current Price | ₹ 168 |
| High / Low | ₹ 221 / 132 |
| Stock P/E | |
| Book Value | ₹ 61.4 |
| Dividend Yield | 0.08 % |
| ROCE | 2.69 % |
| ROE | -3.58 % |
| Face Value | ₹ 10.0 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Mar 2023 | 2,163.58 | 50.11 | 16.24% |
| Jun 2023 | 1,748.85 | -98.58 | 7.57% |
| Sep 2023 | 1,911.38 | 5.02 | 13.90% |
| Dec 2023 | 1,958.57 | 10.11 | 13.70% |
| Mar 2024 | 2,552.36 | 101.27 | 20.76% |
| Jun 2024 | 1,951.14 | -88.64 | 10.48% |
| Sep 2024 | 2,241.75 | 22.59 | 15.24% |
| Dec 2024 | 2,204.22 | 3.68 | 15.32% |
| Mar 2025 | 2,754.07 | 153.50 | 20.37% |
| Jun 2025 | 1,933.71 | -81.70 | 5.52% |
| Sep 2025 | 2,043.72 | -99.22 | 7.76% |
| Dec 2025 | 2,139.87 | -136.19 | 9.15% |
| Mar 2026 | 2,751.77 | -8.83 | 16.74% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 34.78% |
| FIIs | 39.28% |
| DIIs | 4.98% |
| Public | 20.57% |
| Others | 0.39% |
| No. of Shareholders | 2,41,359 |
Pros and Cons
Pros
Cons
- Primary trend direction remains weak, stuck underneath major defensive supply barriers.
Related NSE Stocks
CIE Automotive India Limited
View Share Price Analysis →Sumitomo Chemical India Limited
View Share Price Analysis →KPIT Technologies Limited
View Share Price Analysis →Olectra Greentech Limited
View Share Price Analysis →Godrej Consumer Products Limited
View Share Price Analysis →ICICI Prudential Asset Management Company Limited
View Share Price Analysis →Aegis Vopak Terminals Limited
View Share Price Analysis →Blue Jet Healthcare Limited
View Share Price Analysis →Ircon International Limited
View Share Price Analysis →Bank of India
View Share Price Analysis →Neuland Laboratories Limited
View Share Price Analysis →DLF Limited
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Piramal Pharma Ltd share?
Based on the latest closing data, the technical momentum for Piramal Pharma Ltd is currently evaluated as Bearish. The stock is exhibiting an RSI (14) of 65.2, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (167.73) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Piramal Pharma Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Piramal Pharma Ltd today centers at a Pivot Point (PP) of ₹169.04. Upside resistance challenges are calculated at R1: ₹171.95, R2: ₹176.22, and R3: ₹179.13. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹164.77, S2: ₹161.86, and S3: ₹157.59.
How does the fundamental ROE and P/E ratio look for Piramal Pharma Ltd?
Piramal Pharma Ltd is currently trading with a valuation metrics context of a Stock P/E of , against a core structural efficiency Return on Equity (ROE) standing at -3.58 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 3, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Piramal Pharma Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Chronic Downtrend / Potential Value Trap (Neutral / Avoid). Piramal Pharma Ltd c... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of A+, a Relative Strength (RS) ranking of 43, and long-term trend backing from the TI65 indicator (Neutral pattern).